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INTRODUCTION
A decade after physicians (including psychiatrists) endorsed the shift toward evidence-based
medicine, the world’s largest association of psychologists, the American Psychological Association
(APA), belatedly but officially embraced the tenets of evidence-based practice (EBP) [American
Psychological Association (APA), 2006]. Other clinical psychology associations, including the
Canadian Psychological Association, soon followed suit (Canadian Psychological Association,
2012). The interpretation of medical evidence is deeply entwined with ethics; although mainstream
medicine has until recently paid relatively little attention to the ethical repercussions of evidence-
based practice, the neglect in the field of psychological treatments is even more glaring.
Why does EBP matter for the ethical practice of psychological treatments? Evidence carries
ethical imperatives. Both the decision about what is considered to be beneficial in psychotherapy,
and the current paucity of research regarding the potential negative effects of psychological
treatments, carry ethical implications. We argue that the failure to pay attention to psychotherapy
research effectively risks undermining key requisites included in professional codes of practice for
clinical psychology, psychiatry, social work, and allied fields. First, EBP bears repercussions for
the clinician’s duty of professional competence, or what O’Donohue and Henderson (1999) have
collectively termed “epistemic duties”—the responsibility to acquire and apply accurate knowledge.
Second, EBP is relevant to the duty to respect patient autonomy—namely, the patient’s right to
make informed decisions concerning his or her treatment plans.
Evidence shows that there are divergent views about the importance, and feasibility, of informed
consent among practicing psychotherapists (e.g., Croarkin et al., 2003; Barnett et al., 2007; Goddard
et al., 2008). Some of this variation, we argue, probably owes to differences in opinion about what is
materially relevant to patients in deciding to undergo psychotherapy; other omissions of informed
consent may persist because of continued debate and confusion about what constitutes “evidence”
in psychotherapy research and practice. We argue that—despite these challenges—the profession
of psychotherapy must find ways to meet the moral obligation of providing adequate informed
consent to patients.
EVIDENCE-BASED PRACTICE AND ETHICAL DUTIES
Professional competence—the ability to accurately assess problems, diagnose psychological
disorders, recommend an appropriate course of treatment, and successfully carry out that
treatment—varies depending on the degree to which the clinician keeps up to date with the latest
research and effectively evaluates the evidence. The APA requires that clinicians be trained in EBP
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to be equipped to appraise the range of evidence regarding
the efficacy of different forms of psychotherapy, to recognize
the strengths and limitations of clinical intuition, and to
understand the importance of patient preferences and values,
as well as the relevance of the socio-cultural context in treating
clients. In this way, the APA acknowledges that EBP requires
knowledge of controlled clinical trials, but also underlines that
trial data have inherent limitations. For example, such trials
can be unrepresentative of individual patients given that they
can be largely insensitive to such factors as age of patient,
and comorbidity [American Psychological Association (APA),
2006; cf. Greenhalgh et al., 2014; Sheridan and Julian, 2016].
The APA also emphasizes the importance of keeping up to
date with the latest process—and not merely outcome—data on
how psychotherapies work [American Psychological Association
(APA), 2006].
The duty to be professionally competent carries significant
additional implications for the duty to respect patient autonomy.
Historically, paternalismwas the largely unquestioned bedrock of
healthcare practice. Paternalism is defined as “the interference of
a state or an individual by another person, against their will, and
defended or motivated by the claim that the person interfered
with will be better off or protected from harm” (Dworkin,
2010); it was defended on the grounds that doctors were the
gatekeepers of medical knowledge, as well as the best judges of
how to use that knowledge to serve the interests of patients.
Today, healthcare ethics codes (in the West) eschew paternalism:
professional clinicians are now obliged to be truthful and to
provide adequate disclosure to patients about their diagnosis,
the risks and benefits of various treatment options, and their
duration and costs (Trachsel et al., 2015; Blease et al., 2016;
Trachsel and Gaab, 2016). However, the quality of disclosures
to patients depends on practitioner knowledge, illustrating
once again why standards of evidence are enmeshed with
ethics.
EVIDENCE OF FAILURES IN INFORMED
CONSENT
Evidence suggests that psychotherapists may be routinely failing
to provide adequate informed consent to patients (Dsubanko-
Obermayr and Baumann, 1998; Croarkin et al., 2003; Barnett
et al., 2007; Goddard et al., 2008). Surveys in the US and UK
reveal broad variation among psychotherapists, as well as among
psychotherapy schools, in beliefs and practices with respect to
information disclosure (Somberg et al., 1993; Croarkin et al.,
2003; Martindale et al., 2009). Psychiatrists and adherents of
psychodynamic psychotherapy appear to be especially doubtful
about the practicability and importance of informed consent
(Croarkin et al., 2003; Goddard et al., 2008). Yet even in cases in
which therapists routinely disclose information about the specific
techniques of therapy—as we later argue—this information may
be insufficient for adequate informed consent.
There is evidence that standards of disclosure relate to,
and may influence, outcome in psychotherapy. A recent UK
study found that patients who reported receiving insufficient
information about therapy before it started were significantly
more likely to report adverse effects of treatment (Crawford
et al., 2016). This finding, although correlational and open to
rival interpretations (e.g., therapists who fail to provide informed
consent may be less competent in general), supports the notion
that the provision of information about therapy helps demystify
the treatment process, may reduce anxiety about treatment, and
may increase trust between therapist and patient, contributing to
better outcomes (Beahrs and Gutheil, 2001; Snyder and Barnett,
2006). It is also conceivable that negative effects may arise from
failures to provide understandable information to patients, or
that negative effects are a consequence of the manner in which
information disclosures are conveyed to patients.
It is worth emphasizing that there are ongoing challenges
associated with providing open and honest disclosures in medical
practice, and perhaps especially in the context of patients
with severe mental health problems, which can sometimes
impair judgment, comprehension, or both. At the same time,
strong arguments are required to justify paternalistic action
in any professional healthcare context. Indeed, even in those
circumstances in which health professionals determine that a
patient has impaired mental functioning, this does not entail
that the duty to provide informed consent be overridden. For
example, the UK’s Mental Capacity Act of 2005 states that there
must be a presumption of capacity for patients to make treatment
decisions; in addition, the burden is on health professionals
to demonstrate that patients lack any such capacity (UK
Department for Constitutional Affairs, 2005). Notwithstanding
these pronouncements, when it comes to informed consent
there may be practical challenges for psychotherapists who
are regularly faced with patients who are extremely anxious,
depressed, or agitated as well as those with pronounced psychotic
features. The key challenge, then, is to find ways to meet
the obligation of adequate disclosure while recognizing the
contextual sensitivities involved in providing comprehensible
information to patients.
EXPLANATIONS FOR PROBLEMS WITH
INFORMED CONSENT
Why does informed consent to psychotherapy appear to be
“vastly underestimated by many psychologists?” (Barnett et al.,
2007). We propose that there are three main reasons for the
resistance to informed consent on the part of many practitioners.
Informed Consent is a “Process”
First, informed consent to therapy is a process, rather than as a
one-time disclosure of information, such as occurs in biomedical
contexts. Some psychotherapists may erroneously believe that
the procedural nature of understanding how therapy works is
a sufficient reason to dismiss or overlook formal disclosure
(Barnett et al., 2007). To overcome any such misconceptions,
Barnett et al. propose that a combination of written and verbal
disclosure of information be provided to patients prior to
treatment, but that disclosure should additionally be an ongoing,
active exchange of information as therapy ensues.
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The Complexities of Psychotherapy
Research
Second, psychotherapy research is highly contentious. Compared
with the evaluation of psychopharmacological treatments,
psychotherapy research is even more difficult to interpret.
Debate focuses largely on what constitutes “evidence” in
psychotherapy research (Tanenbaum, 2006; Stuart and Lilienfeld,
2007; Goldfried, 2013). Although there is not the space to
evaluate and appraise the extensive, ongoing debate about
the nature of EBP, we highlight two salient points that we
believe transcend this debate, and that are relevant to informed
consent to psychotherapy. First, subjective impressions of efficacy
based largely or entirely on personal clinical observations can
be misleading. A robust body of research strongly suggests
that such impressions are frequently inaccurate (Lilienfeld
et al., 2014; Casarett, 2016). Second, although there is still
disagreement regarding the effectiveness of specific techniques
in therapy (e.g., insight-techniques in psychodynamic therapies,
or cognitive restructuring techniques in cognitive-behavioral
therapy) a large body of research suggests that non-specific
factors, such as therapist empathy and the working alliance,
should be taken into account when it comes to assessments of
psychotherapeutic efficacy. For example, therapist characteristics
appear to be important predictors of outcome and in some
cases—for example, major depressive disorder—it has been
argued that such factors may be more predictive than the
specific therapeutic modality (Cuijpers et al., 2008; Wampold
and Imel, 2015). Although, this research is controversial, there
is widespread consensus among psychotherapy researchers and
psychotherapists that—whatever the role of specific factors—the
so-called common factors in therapy—are significant mediators
of change in treatment (Lambert and Barley, 2002; Huppert et al.,
2006; Marcus et al., 2014; Cuijpers, 2016).
Neglect of Research on Negative Effects
Finally, unlike in pharmacology, evidence of possible negative
effects of psychological treatments is both under-researched
and largely underappreciated in clinical psychology and allied
fields. The routine failure to consider the possible harms of
psychotherapy may stem, in part, from intuitive ontological
considerations: namely, in psychotherapy the treatment
modality involves “talking” rather than the administration of a
“physical” treatment such as a drug or surgery (Blease, 2015b).
Findings indicate that approximately 10% of patients experience
worsening of symptoms following long term treatment in
psychotherapy—although it is unclear what proportion of
these deterioration effects is due to the treatment, as opposed
to a naturally-occurring worsening of symptoms, negative
life events outside of therapy, or other influences (Lilienfeld,
2007). In their UK study, Crawford et al. (2016) reported that
1 in 20 patients who enter into psychological therapies report
long-lasting negative effects of treatment. At an institutional
level, unlike drug treatments in which the FDA requires adverse
risks of medications to be investigated and listed, there are no
comparable requirements for psychological treatments (Duggan
et al., 2014; Markowitz and Milrod, 2015). The longstanding lack
of attention to potential harms of psychotherapy may perpetuate
the erroneous assumption that psychotherapy carries negligible
risk.
FUTURE DIRECTIONS: WHAT AND HOW
TO DISCLOSE INFORMATION TO
PATIENTS?
EBP—in its broadest sense—requires therapists to attempt to put
aside or find ways to compensate for their biases, and to approach
psychotherapy research systematically. Although there is ongoing
debate about how to interpret process and outcome research
evidence in psychotherapy, there is a duty among therapists not
only keep up to date with findings about specific treatments,
but to be well-informed about broader debates regarding the
potential mechanisms andmediators of therapeutic outcomes. As
noted, a wide range of research suggests that explanations for the
techniques involved in psychological treatments cannot be taken
at face value. For example, given the evidence for the importance
of the common factors across different forms of psychotherapy,
such as the working alliance, therapist empathy, and the patients’
expectations about treatment effectiveness, a strong case can be
made for their inclusion in initial information disclosures (Gaab
et al., 2015; Blease et al., 2016). It is also likely that there are
ways of disclosing the importance of the therapeutic relationship
to patients, for example, without undermining that relationship
(Blease, 2015a,b; Trachsel and Gaab, 2016), and we strongly
encourage research on this issue.
Clients also have a right to be fully informed about the
efficacy and effectiveness of specific techniques in therapy. For
example, patients with obsessive-compulsive disorder (OCD)
have a right to know that exposure and response prevention is
the best-supported intervention for their condition—and hence
a first-line treatment (Olatunji et al., 2013). Additionally, when
it comes to overall efficacy claims, treatment specificity tends to
be considerably higher for certain conditions than for others; for
example, in contrast to OCD, for which behavioral interventions
are the clear treatment of choice, major depression tends to
respond to a broad range of psychological treatments (e.g.,
behavioral, cognitive, interpersonal; see Hollon et al., 2002).
Moreover, because certain conditions, major depression again
being a prime example, appear to be etiologically heterogeneous,
it unlikely that even a highly efficacious intervention will work
for virtually all clients. Therefore, clients need to be informed
that, depending on their diagnosis, therapeutic interventionsmay
work well for most patients but not all. The point is that research
must percolate into disclosure procedures: patients have a right
to be furnished with adequate, understandable information about
treatment techniques, the importance of common therapeutic
factors as well as specific therapeutic techniques, and the risks of
harm from a minority of psychological treatments (see Lilienfeld,
2007).
Finally, we recommend that informed consent to
psychotherapy is best conceived as a process—initial disclosures
of information will require active, ongoing refinement as
therapy ensues. Research suggests that including ongoing patient
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feedback during therapy is one important means of monitoring
progress, thereby helping therapists to enhance patient outcomes
(Lambert et al., 2001; Sapyta et al., 2005; Shimokawa et al., 2010;
Beidas et al., 2015). The bidirectional flow of information about
how therapy works, as well as how patients believe therapy is
progressing, should be built into the therapeutic process (Barnett
et al., 2007).
CONCLUSIONS
Therapists should decisively disavow the pervasive assumption
that psychotherapies—although generally effective—carry no risk
of harm, and that disclosure (or its omission) somehow carries
a different moral valence for psychotherapy than for biomedical
treatments. Legally and morally, licensed clinical and counseling
psychologists, psychiatrists, and other psychotherapists are duty-
bound to eschew healthcare paternalism. Patients deserve to
be fully informed if they are to make autonomous choices
regarding psychological treatment modalities. Psychotherapy
must incorporate best evidence into training and practice if it
is to establish and maintain high ethical standards of care. The
discussion about how best to accomplish this crucial goal must
now begin in earnest.
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